Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

N-Acetylcysteine for Patients With COPD and Chronic Bronchitis
Effects of High-Dose N-Acetylcysteine on Respiratory Health Status in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis: A Randomized, Placebo-Controlled Trial-2
Status: Enrolling
Updated:  9/25/2013
HealthPartners Institute for Education and Research
mi
from
Saint Paul, MN
N-Acetylcysteine for Patients With COPD and Chronic Bronchitis
Effects of High-Dose N-Acetylcysteine on Respiratory Health Status in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis: A Randomized, Placebo-Controlled Trial-2
Status: Enrolling
Updated: 9/25/2013
HealthPartners Institute for Education and Research
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)
Sequential, Two-period Study to Assess the Pharmacokinetics, Safety & Tolerability of Single and Multiple Oral Doses of AFQ056 in Patients With FXS (Fragile X Syndrome) Aged 5-11 Years (Cohort 1) and 3-4 Years (Cohort 2)
Status: Enrolling
Updated:  10/16/2013
Novartis Investigative site
mi
from
Los Angeles, CA
Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)
Sequential, Two-period Study to Assess the Pharmacokinetics, Safety & Tolerability of Single and Multiple Oral Doses of AFQ056 in Patients With FXS (Fragile X Syndrome) Aged 5-11 Years (Cohort 1) and 3-4 Years (Cohort 2)
Status: Enrolling
Updated: 10/16/2013
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)
Sequential, Two-period Study to Assess the Pharmacokinetics, Safety & Tolerability of Single and Multiple Oral Doses of AFQ056 in Patients With FXS (Fragile X Syndrome) Aged 5-11 Years (Cohort 1) and 3-4 Years (Cohort 2)
Status: Enrolling
Updated:  10/16/2013
Novartis Investigative Site
mi
from
Chicago, IL
Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)
Sequential, Two-period Study to Assess the Pharmacokinetics, Safety & Tolerability of Single and Multiple Oral Doses of AFQ056 in Patients With FXS (Fragile X Syndrome) Aged 5-11 Years (Cohort 1) and 3-4 Years (Cohort 2)
Status: Enrolling
Updated: 10/16/2013
Novartis Investigative Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)
Sequential, Two-period Study to Assess the Pharmacokinetics, Safety & Tolerability of Single and Multiple Oral Doses of AFQ056 in Patients With FXS (Fragile X Syndrome) Aged 5-11 Years (Cohort 1) and 3-4 Years (Cohort 2)
Status: Enrolling
Updated:  10/16/2013
Novartis Investigative Site
mi
from
Knoxville, TN
Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)
Sequential, Two-period Study to Assess the Pharmacokinetics, Safety & Tolerability of Single and Multiple Oral Doses of AFQ056 in Patients With FXS (Fragile X Syndrome) Aged 5-11 Years (Cohort 1) and 3-4 Years (Cohort 2)
Status: Enrolling
Updated: 10/16/2013
Novartis Investigative Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
Evaluation of Benefit for Treatment of Single Sided Deafness (SSD) Between Two Bone Conduction Prosthetic Devices; Osseointegrated Implant Versus Maxilla Anchored Removable Oral Appliance ("SoundBite")
Evaluation of Benefit for Treatment of Single Sided Deafness (SSD) Between Two Bone Conduction Prosthetic Devices; Osseointegrated Implant Versus Maxilla Anchored Removable Oral Appliance ("SoundBite")
Status: Enrolling
Updated:  10/25/2013
Arizona Ear Center
mi
from
Phoenix, AZ
Evaluation of Benefit for Treatment of Single Sided Deafness (SSD) Between Two Bone Conduction Prosthetic Devices; Osseointegrated Implant Versus Maxilla Anchored Removable Oral Appliance ("SoundBite")
Evaluation of Benefit for Treatment of Single Sided Deafness (SSD) Between Two Bone Conduction Prosthetic Devices; Osseointegrated Implant Versus Maxilla Anchored Removable Oral Appliance ("SoundBite")
Status: Enrolling
Updated: 10/25/2013
Arizona Ear Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Evaluation of Benefit for Treatment of Single Sided Deafness (SSD) Between Two Bone Conduction Prosthetic Devices; Osseointegrated Implant Versus Maxilla Anchored Removable Oral Appliance ("SoundBite")
Evaluation of Benefit for Treatment of Single Sided Deafness (SSD) Between Two Bone Conduction Prosthetic Devices; Osseointegrated Implant Versus Maxilla Anchored Removable Oral Appliance ("SoundBite")
Status: Enrolling
Updated:  10/25/2013
Michigan Ear Institute
mi
from
Novi, MI
Evaluation of Benefit for Treatment of Single Sided Deafness (SSD) Between Two Bone Conduction Prosthetic Devices; Osseointegrated Implant Versus Maxilla Anchored Removable Oral Appliance ("SoundBite")
Evaluation of Benefit for Treatment of Single Sided Deafness (SSD) Between Two Bone Conduction Prosthetic Devices; Osseointegrated Implant Versus Maxilla Anchored Removable Oral Appliance ("SoundBite")
Status: Enrolling
Updated: 10/25/2013
Michigan Ear Institute
mi
from
Novi, MI
Click here to add this to my saved trials
Evaluation of Benefit for Treatment of Single Sided Deafness (SSD) Between Two Bone Conduction Prosthetic Devices; Osseointegrated Implant Versus Maxilla Anchored Removable Oral Appliance ("SoundBite")
Evaluation of Benefit for Treatment of Single Sided Deafness (SSD) Between Two Bone Conduction Prosthetic Devices; Osseointegrated Implant Versus Maxilla Anchored Removable Oral Appliance ("SoundBite")
Status: Enrolling
Updated:  10/25/2013
Ear Medical Group
mi
from
San Antonio, TX
Evaluation of Benefit for Treatment of Single Sided Deafness (SSD) Between Two Bone Conduction Prosthetic Devices; Osseointegrated Implant Versus Maxilla Anchored Removable Oral Appliance ("SoundBite")
Evaluation of Benefit for Treatment of Single Sided Deafness (SSD) Between Two Bone Conduction Prosthetic Devices; Osseointegrated Implant Versus Maxilla Anchored Removable Oral Appliance ("SoundBite")
Status: Enrolling
Updated: 10/25/2013
Ear Medical Group
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy of Gralise® for Chronic Pelvic Pain
Efficacy of Gralise® for Chronic Pelvic Pain
Status: Enrolling
Updated:  10/29/2013
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Efficacy of Gralise® for Chronic Pelvic Pain
Efficacy of Gralise® for Chronic Pelvic Pain
Status: Enrolling
Updated: 10/29/2013
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Metabolic Screening in Patients With Donnai-Barrow Syndrome
Metabolic Screening in Patients With Donnai-Barrow Syndrome
Status: Enrolling
Updated:  11/7/2013
Massachusetts General Hospital
mi
from
Boston, MA
Metabolic Screening in Patients With Donnai-Barrow Syndrome
Metabolic Screening in Patients With Donnai-Barrow Syndrome
Status: Enrolling
Updated: 11/7/2013
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Effect of Vitamin D Supplementation on Endothelial Function in Obese Adolescents
Effect of Vitamin D Supplementation on Endothelial Function in Obese Adolescents
Status: Enrolling
Updated:  11/11/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Effect of Vitamin D Supplementation on Endothelial Function in Obese Adolescents
Effect of Vitamin D Supplementation on Endothelial Function in Obese Adolescents
Status: Enrolling
Updated: 11/11/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated:  11/14/2013
Novartis Investigative Site
mi
from
Sacramento, CA
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated: 11/14/2013
Novartis Investigative Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated:  11/14/2013
Novartis Investigative site
mi
from
Aurora, CO
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated: 11/14/2013
Novartis Investigative site
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated:  11/14/2013
Novartis Investigative Site
mi
from
Decatur, GA
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated: 11/14/2013
Novartis Investigative Site
mi
from
Decatur, GA
Click here to add this to my saved trials
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated:  11/14/2013
Novartis Investigator Site
mi
from
Chicago, IL
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated: 11/14/2013
Novartis Investigator Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated:  11/14/2013
Novartis Investigative Site
mi
from
Indianapolis, IN
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated: 11/14/2013
Novartis Investigative Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated:  11/14/2013
Novartis Investigative site
mi
from
Boston, MA
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated: 11/14/2013
Novartis Investigative site
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated:  11/14/2013
Novartis Investigative Site
mi
from
Springfield, MA
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated: 11/14/2013
Novartis Investigative Site
mi
from
Springfield, MA
Click here to add this to my saved trials
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated:  11/14/2013
Novartis Investigative Site
mi
from
Omaha, NE
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated: 11/14/2013
Novartis Investigative Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated:  11/14/2013
Novartis Investigative Site
mi
from
Staten Island, NY
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated: 11/14/2013
Novartis Investigative Site
mi
from
Staten Island, NY
Click here to add this to my saved trials
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated:  11/14/2013
Novartis Investigative Site
mi
from
Greenwood, SC
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated: 11/14/2013
Novartis Investigative Site
mi
from
Greenwood, SC
Click here to add this to my saved trials
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated:  11/14/2013
Novartis Investigative Site
mi
from
Nashville, TN
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated: 11/14/2013
Novartis Investigative Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated:  11/14/2013
Novartis Investigative site
mi
from
Dallas, TX
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated: 11/14/2013
Novartis Investigative site
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated:  11/14/2013
Novartis Investigative Site
mi
from
Houston, TX
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated: 11/14/2013
Novartis Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated:  11/14/2013
Novartis Investigative Site
mi
from
Bellevue, WA
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated: 11/14/2013
Novartis Investigative Site
mi
from
Bellevue, WA
Click here to add this to my saved trials
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated:  11/14/2013
Novartis Investigative Site
mi
from
Seattle, WA
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome
Status: Enrolling
Updated: 11/14/2013
Novartis Investigative Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Gene Therapy for Tay-Sachs Disease
Gene Therapy for Tay-Sachs Disease (Phase 1: Natural History Data Gather)
Status: Enrolling
Updated:  12/17/2013
Data Management and Coordinating Center (DMCC), Univ. of South Florida
mi
from
Tampa, FL
Gene Therapy for Tay-Sachs Disease
Gene Therapy for Tay-Sachs Disease (Phase 1: Natural History Data Gather)
Status: Enrolling
Updated: 12/17/2013
Data Management and Coordinating Center (DMCC), Univ. of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Gene Therapy for Tay-Sachs Disease
Gene Therapy for Tay-Sachs Disease (Phase 1: Natural History Data Gather)
Status: Enrolling
Updated:  12/17/2013
Univ of Minnesota
mi
from
Minneapolis, MN
Gene Therapy for Tay-Sachs Disease
Gene Therapy for Tay-Sachs Disease (Phase 1: Natural History Data Gather)
Status: Enrolling
Updated: 12/17/2013
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Pistachios, Performance, Metabolomics
Influence of Pistachios on Performance and Exercise-induced Inflammation, Oxidative Stress, and Immune Dysfunction in Athletes: a Metabolomics-based Approach.
Status: Enrolling
Updated:  12/19/2013
ASU Human Performance Laboratory, North Carolina Research Campus
mi
from
Kannapolis, NC
Pistachios, Performance, Metabolomics
Influence of Pistachios on Performance and Exercise-induced Inflammation, Oxidative Stress, and Immune Dysfunction in Athletes: a Metabolomics-based Approach.
Status: Enrolling
Updated: 12/19/2013
ASU Human Performance Laboratory, North Carolina Research Campus
mi
from
Kannapolis, NC
Click here to add this to my saved trials
Safety and Tolerability of Antioxidant (AT-001)for Reducing Brain Oxidative Stress
Multiple-ascending Dose Clinical Trial of the Safety and Tolerability of Antioxidant (AT-001) Treatment for Reducing Brain Oxidative Stress
Status: Enrolling
Updated:  1/22/2014
University of Kentucky Alzheimer's Disease Research Center
mi
from
Lexington, KY
Safety and Tolerability of Antioxidant (AT-001)for Reducing Brain Oxidative Stress
Multiple-ascending Dose Clinical Trial of the Safety and Tolerability of Antioxidant (AT-001) Treatment for Reducing Brain Oxidative Stress
Status: Enrolling
Updated: 1/22/2014
University of Kentucky Alzheimer's Disease Research Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Identifiable Factors That May Lead to Postoperative Nausea and Vomiting After Simple Laparoscopic Appendectomy
Status: Enrolling
Updated:  1/22/2014
Nationwide Children's Hospital
mi
from
Columbus, OH
Identifiable Factors That May Lead to Postoperative Nausea and Vomiting After Simple Laparoscopic Appendectomy
Status: Enrolling
Updated: 1/22/2014
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Face Transplantation Clinical Trial
Protocol for Composite Facial Allograft Transplant
Status: Enrolling
Updated:  1/28/2014
Cleveland Clinic
mi
from
Cleveland, OH
Face Transplantation Clinical Trial
Protocol for Composite Facial Allograft Transplant
Status: Enrolling
Updated: 1/28/2014
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
Children's Hospital of Orange County
mi
from
Orange, CA
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
Children's Hospital of Orange County
mi
from
Orange, CA
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
UCSF School of Medicine
mi
from
San Francisco, CA
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
UCSF School of Medicine
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
Childrens National Medical Center
mi
from
Washington,
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
University of Miami Cancer Center
mi
from
Miami, FL
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
University of Miami Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
Children's Healthcare of Atlanta/Emory University
mi
from
Atlanta, GA
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
Children's Healthcare of Atlanta/Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
Lurie Children's Hospital
mi
from
Chicago, IL
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
Lurie Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
Johns Hopkins University
mi
from
Baltimore, MD
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
Dana Farber
mi
from
Boston, MA
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
Dana Farber
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
C.S Mott Children's Hospital
mi
from
Ann Arbor, MI
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
C.S Mott Children's Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
Childrens Hospital & Clinics of Minnesota
mi
from
Minneapolis, MN
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
Childrens Hospital & Clinics of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
University of Minnesota Children's Hospital
mi
from
Minneapolis, MN
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
University of Minnesota Children's Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
Children's Mercy Hospital
mi
from
Kansas City, MO
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
Children's Hospital New York-Presbyterian
mi
from
New York, NY
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
Children's Hospital New York-Presbyterian
mi
from
New York, NY
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
New York University Medical Center
mi
from
New York, NY
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
New York University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
Levine Children's Hospital at Carolinas Medical Center
mi
from
Charlotte, NC
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
Levine Children's Hospital at Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
Nationwide Children's Hospital
mi
from
Columbus, OH
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  1/31/2014
Oregon Health and Science University
mi
from
Portland, OR
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 1/31/2014
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials